ClinConnect ClinConnect Logo
Search / Trial NCT02493478

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Jul 8, 2015

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Intubation Advanced Airway Intervention Intensive Care Unit

ClinConnect Summary

This clinical trial is focused on improving the safety and quality of procedures used to help children breathe in critical situations, such as when they need to be intubated (a tube placed in the windpipe to assist with breathing). These advanced airway procedures are often performed in pediatric intensive care units (ICUs) and emergency departments (EDs) and can be quite risky. The goal of the study is to find better ways to carry out these procedures, especially in cases where they are difficult or have failed in the past.

Children of all ages who have experienced specific breathing emergencies, like needing intubation or other airway interventions, may be eligible to participate. The trial is currently recruiting participants and welcomes children regardless of gender. If your child is involved, you can expect to be part of a study that aims to make these life-saving procedures safer for kids in the future. It's important to note that this study will not include children who have had these airway procedures done in operating rooms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary advanced airway events (on patients of all ages) in the PICU, CICU, NICU, DR and ED including: Tracheal Intubation, Laryngeal mask placement, Emergency tracheostomy and/or cricothyrotomy
  • Failed extubation attempts or unplanned extubations that require re-intubation will be considered a new primary intubation.
  • Exclusion Criteria:
  • Primary advanced airway events (tracheal intubations, laryngeal mask placement, emergency tracheostomy and/or cricothyrotomy) in the Operating Suites.

About Children's Hospital Of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.

Locations

Philadelphia, Pennsylvania, United States

Milwaukee, Wisconsin, United States

Springfield, Massachusetts, United States

Vancouver, British Columbia, Canada

Miami, Florida, United States

Phoenix, Arizona, United States

Atlanta, Georgia, United States

Aurora, Colorado, United States

Seattle, Washington, United States

Portland, Oregon, United States

Columbus, Ohio, United States

Seattle, Washington, United States

Indianapolis, Indiana, United States

Morristown, New Jersey, United States

Lebanon, New Hampshire, United States

Albany, New York, United States

Calgary, Alberta, Canada

Little Rock, Arkansas, United States

Philadelphia, Pennsylvania, United States

Boston, Massachusetts, United States

Providence, Rhode Island, United States

Pittsburgh, Pennsylvania, United States

Hiroshima, , Japan

Auckland, , New Zealand

Akron, Ohio, United States

Raleigh, North Carolina, United States

New Haven, Connecticut, United States

Madera, California, United States

Omaha, Nebraska, United States

New Hyde Park, New York, United States

Bronx, New York, United States

Dallas, Texas, United States

New Haven, Connecticut, United States

Setagaya Ku, Tokyo, Japan

Memphis, Tennessee, United States

Baltimore, Maryland, United States

Raleigh, North Carolina, United States

Montreal, Quebec, Canada

Charlottesville, Virginia, United States

Richmond, Virginia, United States

New York, New York, United States

Singapore, , Singapore

Hershey, Pennsylvania, United States

Atlanta, Georgia, United States

Augusta, Georgia, United States

South Bend, Indiana, United States

Lexington, Kentucky, United States

Louisville, Kentucky, United States

Baltimore, Maryland, United States

Saint Paul, Minnesota, United States

Saint Paul, Minnesota, United States

Buffalo, New York, United States

Rochester, New York, United States

Stony Brook, New York, United States

Valhalla, New York, United States

Durham, North Carolina, United States

Cincinnati, Ohio, United States

Hershey, Pennsylvania, United States

Burlington, Vermont, United States

Madison, Wisconsin, United States

Calgary, Alberta, Canada

Montréal, Quebec, Canada

Luebeck, , Germany

Bangalore, , India

Roma, , Italy

Kobe, , Japan

Obu, , Japan

Saitama, , Japan

Shimotsuke, , Japan

Tokyo, , Japan

Singapore, , Singapore

Herston, , Australia

Parkville, , Australia

Birmingham, Alabama, United States

Chicago, Illinois, United States

Wilmington, Delaware, United States

Cleveland, Ohio, United States

Austin, Texas, United States

Vienna, , Austria

Winnipeg, , Canada

Bengaluru, Karnataka, India

Cardiff, Wales, United Kingdom

Irving, Texas, United States

San Antonio, Texas, United States

San Antonio, Texas, United States

Madison, Wisconsin, United States

Shorewood Hills, Wisconsin, United States

Patients applied

0 patients applied

Trial Officials

Vinay Nadkarni, MD. MS

Principal Investigator

Children's Hospital of Philadelphia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials